KALYANI MEDITIMES PRIVATE LIMITED
Founded in 2016
About KALYANI MEDITIMES PRIVATE LIMITED
MediTimes is a healthcare technology platform that utilizes artificial intelligence and machine learning. It connects doctors, pharmacies, laboratories, and diagnostics firms through a seamless portal. MediTimes aims to promote the use of e-Prescriptions and clinical management in India by providing doctors with the MIND (MediTimes Intelligence Network Doctor) offering. This allows doctors to dispense e-Prescriptions and follow up with patients using their smartphones. With features like native language processing and speech to text, even non-tech savvy doctors can easily use MediTimes. The platform aims to save doctors 25-30% of their clinic (Show more)
Public Links of KALYANI MEDITIMES PRIVATE LIMITED
Frequently Asked Questions (FAQ)
When was KALYANI MEDITIMES PRIVATE LIMITED founded?
KALYANI MEDITIMES PRIVATE LIMITED was founded in the year 2016.
Who are the founders of KALYANI MEDITIMES PRIVATE LIMITED?
KALYANI MEDITIMES PRIVATE LIMITED is founded by Krish Ramesh and Sundar Krishnan.
What are the focus areas of KALYANI MEDITIMES PRIVATE LIMITED?
Who are KALYANI MEDITIMES PRIVATE LIMITED's competitors?
Possible competitors of KALYANI MEDITIMES PRIVATE LIMITED may include Advintel Medicare Private Limited, Cryptappz Technologies Llp, Docconsult and 7 others.
Get Access to Complete Information
Signup NowDetails insufficient or not accurate? Suggest edits
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
